Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

23.22 +0.44 (+1.93%) At close: 03:00PM CST

Nanjing Well Pharmaceutical Group Co.,Ltd.

Building 5, 64 Suning Avenue
Xuzhuang Software Park Xuanwu District
Nanjing 210042
China
86 25 8573 2322
https://www.well-js.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 615

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Renrong Wu	Chairman & CEO	N/A	N/A	1963
Mr. Qunsong Tang	Sec. of the Board of Directors & CFO	N/A	N/A	1967
Mr. Zhengsong Gao	Director, VP & Chief Engineer	N/A	N/A	1965
Mr. Xinguo Chen	Director & VP	N/A	N/A	1968

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables. The company also provides synthetic base oils, such as hydraulic fluids, lubricity additives for metals, metal quenching, base fluids and lubricity additives, synthetic base for compress lubricants, synthetic base oil for gear, base oil of chain lubricants, base stock of engine oil, base stock of heat transfer oil, and base oil of grease; and other products, including painting and coating, textile chemicals, field chemicals, and low foam metal cleaners. It also exports its products to Europe, the United States, Southeast Asia, and internationally. The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020. The company was founded in 2000 and is based in Nanjing, China.

Corporate Governance

Nanjing Well Pharmaceutical Group Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.